Janssen Launches Gut Check Mobile Application to Improve IBD Monitoring

Janssen Launches Gut Check Mobile Application to Improve IBD Monitoring
Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies, recently announced the launch of a novel tool called Gut Check™, which is designed to improve disease monitoring in patients suffering from ulcerative colitis and Crohn’s disease — conditions also referred to as inflammatory bowel diseases (IBD). IBD is estimated to affect around 1.6 million Americans (1

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *